GlassScriptPhysician profile
Scott L Friedberg
NPI 1871615880
$626.02
in general payments reported to CMS, 2019-2025
12 companies · $171 in 2025
The $171 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.97 · 2022: $293 · 2023: $99.38 · 2024: $32.19 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $302.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $165.80 | 2022-2025 | |
| Novo Nordisk INC | $126.13 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Biohaven Pharmaceutical Holding Company LTD. | $95.67 | 2022 | |
| Exact Sciences Corporation | $46.23 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Amgen INC. | $46.02 | 2022-2025 | Prolia, Evenity, Repatha |
| Amarin Pharma, INC. | $37.59 | 2022 | |
| Intercept Pharmaceuticals, INC. | $21.37 | 2025 | |
| Boston Scientific Corporation | $19.92 | 2023 | Watchman Flx |
| Lilly USA, LLC | $18.71 | 2022 | |
| Abbvie INC. | $18.61 | 2022 | |
| Allergan, INC. | $15.82 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Friedberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.